文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脂蛋白(a)浓度在性别特异性差异与 2 型糖尿病患者心血管死亡率的关系。

Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus.

机构信息

Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.

German Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Greifswald, Germany.

出版信息

Cardiovasc Diabetol. 2021 Aug 18;20(1):168. doi: 10.1186/s12933-021-01363-x.


DOI:10.1186/s12933-021-01363-x
PMID:34407812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8375146/
Abstract

BACKGROUND: Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men in individuals with type 2 diabetes mellitus. METHODS: We evaluated data from 7443 individuals (3792 women, 50.9%), aged 20 to 81 years, from two independent population-based investigations, SHIP-0 and MONICA/KORA S3. We analyzed the longitudinal sex-specific associations of lipoprotein(a) with cardiovascular mortality in individuals with and without type 2 diabetes mellitus using Cox regression. RESULTS: During a median follow-up of 20.5 years (136,802 person-years), 657 participants (404 men and 253 women) died of cardiovascular causes. Among individuals without type 2 diabetes mellitus, men had a significantly higher risk for cardiovascular mortality compared to women in unadjusted model and after adjustment. On the other hand, in participants with type 2 diabetes mellitus, the risk for cardiovascular mortality was not different between men and women in the unadjusted model and after adjustment for age, body mass index, low-density lipoprotein-cholesterol, fasting status and study sample (SHIP-0, MONICA/KORA S3). Further adjustment for lipoprotein(a) concentrations had no impact on the hazard ratio (HR) for cardiovascular mortality comparing men versus women in individuals without type 2 diabetes mellitus [HR: 1.94; 95% confidence interval (CI) 1.63 to 2.32; p < 0.001]. In individuals with type 2 diabetes mellitus, however, further adjustment for lipoprotein(a) led to an increased risk for cardiovascular mortality in men and a decreased risk in women resulting in a statistically significant difference between men and women (HR: 1.53; 95% CI 1.04 to 2.24; p = 0.029). CONCLUSIONS: Women are described to have a stronger relative increase in cardiovascular mortality than men when comparing individuals with and without type 2 diabetes mellitus. Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus than in men with type 2 diabetes mellitus might partially explain this finding.

摘要

背景:与没有 2 型糖尿病的个体相比,2 型糖尿病个体的心血管死亡率的相对增加在女性中比男性更高。

方法:我们评估了来自两个独立的基于人群的调查(SHIP-0 和 MONICA/KORA S3)的 7443 名个体(3792 名女性,占 50.9%)的数据。我们使用 Cox 回归分析了脂蛋白(a)与有和没有 2 型糖尿病的个体心血管死亡率的纵向性别特异性关联。

结果:在中位随访 20.5 年(136802 人年)期间,有 657 名参与者(404 名男性和 253 名女性)死于心血管原因。在没有 2 型糖尿病的个体中,男性在未经调整的模型和调整后的模型中,心血管死亡率的风险均显著高于女性。另一方面,在患有 2 型糖尿病的参与者中,在未经调整的模型和调整年龄、体重指数、低密度脂蛋白胆固醇、空腹状态和研究样本(SHIP-0、MONICA/KORA S3)后,男性和女性的心血管死亡率风险无差异。进一步调整脂蛋白(a)浓度对无 2 型糖尿病个体中男性与女性心血管死亡率的危险比(HR)没有影响[HR:1.94;95%置信区间(CI)1.63 至 2.32;p<0.001]。然而,在患有 2 型糖尿病的个体中,进一步调整脂蛋白(a)导致男性的心血管死亡率风险增加,女性的风险降低,导致男性和女性之间存在统计学显著差异(HR:1.53;95%CI 1.04 至 2.24;p=0.029)。

结论:与没有 2 型糖尿病的个体相比,在比较有和没有 2 型糖尿病的个体时,女性描述为心血管死亡率的相对增加更强。与男性相比,患有 2 型糖尿病的女性脂蛋白(a)浓度更高,这可能部分解释了这一发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/7d7e0b196473/12933_2021_1363_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/5e782d84df32/12933_2021_1363_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/6fdd80c4a790/12933_2021_1363_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/7d7e0b196473/12933_2021_1363_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/5e782d84df32/12933_2021_1363_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/6fdd80c4a790/12933_2021_1363_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d85/8375146/7d7e0b196473/12933_2021_1363_Fig3_HTML.jpg

相似文献

[1]
Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus.

Cardiovasc Diabetol. 2021-8-18

[2]
Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

Nephrol Dial Transplant. 2016-11

[3]
Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.

Arterioscler Thromb Vasc Biol. 2016-11

[4]
Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.

Psychosom Med. 2009-9

[5]
Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.

Circulation. 2019-2-19

[6]
Poor structural social support is associated with an increased risk of Type 2 diabetes mellitus: findings from the MONICA/KORA Augsburg cohort study.

Diabet Med. 2016-1

[7]
Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study.

Arch Intern Med. 2002-1-14

[8]
Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.

Atherosclerosis. 2020-3

[9]
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study.

Cardiovasc Diabetol. 2024-8-17

[10]
Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.

J Am Heart Assoc. 2020-1-4

引用本文的文献

[1]
Assessment of the trends in lipoprotein(a) concentration in high-risk cardiovascular patients: A retrospective study.

Qatar Med J. 2025-3-5

[2]
Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort.

JACC Adv. 2025-3

[3]
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review.

Pharmaceuticals (Basel). 2024-7-9

[4]
Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without.

Int J Gen Med. 2023-8-8

[5]
Lipoprotein(a) As a Risk Factor in a Cohort of Hospitalised Cardiovascular Patients: A Retrospective Clinical Routine Data Analysis.

J Clin Med. 2023-4-29

[6]
Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).

Lipids Health Dis. 2022-12-19

[7]
Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction.

Commun Med (Lond). 2022-7-1

[8]
Non-genetic influences on lipoprotein(a) concentrations.

Atherosclerosis. 2022-5

[9]
High-Resolution Computer Tomography Image Features of Lungs for Patients with Type 2 Diabetes under the Faster-Region Recurrent Convolutional Neural Network Algorithm.

Comput Math Methods Med. 2022

[10]
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.

Int J Mol Sci. 2022-3-25

本文引用的文献

[1]
Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.

Prog Cardiovasc Dis. 2020-4-27

[2]
Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

Curr Opin Lipidol. 2020-6

[3]
Type 2 diabetes-related sex differences in cardiovascular risk: reasons, ramifications, and clinical realities.

Eur Heart J. 2020-4-1

[4]
Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?

Eur Heart J. 2020-4-1

[5]
An update on pharmacotherapies in diabetic dyslipidemia.

Prog Cardiovasc Dis. 2019-8-20

[6]
Statins increase Lp(a) plasma level: is this clinically relevant?

Eur Heart J. 2020-6-21

[7]
Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies.

Clin Ther. 2019-7-13

[8]
Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention.

Mayo Clin Proc. 2019-2

[9]
High lipoprotein(a) and high risk of mortality.

Eur Heart J. 2019-9-1

[10]
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies.

Lancet Diabetes Endocrinol. 2018-5-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索